JoNel Aleccia - Kaiser Health News

The top 12 states using antibody therapies produced by Regeneron and Lilly, which research shows don’t work against omicron, include several Southern states with some of the lowest vaccination rates and California, which ranks among the top 20 for fully vaccinated residents.

The promising antiviral drugs to treat COVID can halt hospitalizations and deaths, but only if they’re given to patients within three to five days of their first symptoms, a narrow window many people won’t meet. Here’s why.

At least three promising antiviral treatments for COVID-19 are being tested in clinical trials, with results expected as soon as late fall or winter.

More than 46,000 U.S. children have lost a parent to COVID. Families say finding even basic grief counseling has been difficult and there’s no coordinated effort to help these children access services or benefits.

COVID-related transplants are surging as hospitals grapple with a growing subset of patients whose organs are “basically destroyed by the virus,” said Dr. Jonathan Orens at Johns Hopkins School of Medicine.

As efforts grow to decriminalize psilocybin, advocates in Washington state are pushing to make magic mushrooms available to dying patients even sooner using Right to Try laws.